Vimarsana
Biggest News Aggregation in the World

Page 10 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

Once-Weekly Insulin Better Than Daily in Type 2 Diabetes - Vimarsana News

Once-Weekly Insulin Better Than Daily in Type 2 Diabetes

Once-weekly insulin icodec reduced A1c levels the same or better than once-daily glargine and degludec.

Targeting mTOR Shows Promise in Cutaneous Sarcoidosis - Vimarsana News

Targeting mTOR Shows Promise in Cutaneous Sarcoidosis

Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.

Rise in Reports Of Fake Weight-loss Drugs Linked to Shortage Of Real Thing, WHO Says - Vimarsana News

Rise in Reports Of Fake Weight-loss Drugs Linked to Shortage Of Real Thing, WHO Says

The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's...

Young Myeloma Specialist Forges Ahead, Gives Back - Vimarsana News

Young Myeloma Specialist Forges Ahead, Gives Back

"Manni" Mohyuddin, MD, reflects on patient needs, compassionate care, medical education, and recent advances in treating multiple myeloma.

Europe Approves Exblifep for UTIs and Pneumonia - Vimarsana News

Europe Approves Exblifep for UTIs and Pneumonia

Exblifep is as effective as piperacillin-tazobactam in the treatment of complicated urinary tract infections, the European Medicines Agency said.